Literature DB >> 20357339

Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model.

Y Shido1, Y Nishida, Y Suzuki, T Kobayashi, N Ishiguro.   

Abstract

We undertook a study of the anti-tumour effects of hyperthermia, delivered via magnetite cationic liposomes (MCLs), on local tumours and lung metastases in a mouse model of osteosarcoma. MCLs were injected into subcutaneous osteosarcomas (LM8) and subjected to an alternating magnetic field which induced a heating effect in MCLs. A control group of mice with tumours received MCLs but were not exposed to an AMF. A further group of mice with tumours were exposed to an AMF but had not been treated with MCLs. The distribution of MCLs and local and lung metastases was evaluated histologically. The weight and volume of local tumours and the number of lung metastases were determined. Expression of heat shock protein 70 was evaluated immunohistologically. Hyperthermia using MCLs effectively heated the targeted tumour to 45 degrees C. The mean weight of the local tumour was significantly suppressed in the hyperthermia group (p = 0.013). The mice subjected to hyperthermia had significantly fewer lung metastases than the control mice (p = 0.005). Heat shock protein 70 was expressed in tumours treated with hyperthermia, but was not found in those tumours not exposed to hyperthermia. The results demonstrate a significant effect of hyperthermia on local tumours and reduces their potential to metastasise to the lung.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357339     DOI: 10.1302/0301-620X.92B4.22814

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

1.  Development of magnetic anionic liposome/atelocollagen complexes for efficient magnetic drug targeting.

Authors:  Yusuke Kono; Taketo Nakai; Hitomi Taguchi; Takuya Fujita
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

2.  Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

Authors:  Kosei Nakajima; Takashi Yanagawa; Hideomi Watanabe; Kenji Takagishi
Journal:  Oncol Rep       Date:  2012-10-01       Impact factor: 3.906

3.  Intravenous magnetic nanoparticle cancer hyperthermia.

Authors:  Hui S Huang; James F Hainfeld
Journal:  Int J Nanomedicine       Date:  2013-07-17

4.  Heat-stimuli-enhanced osteogenesis using clinically available biomaterials.

Authors:  Takehiro Ota; Yoshihiro Nishida; Kunihiro Ikuta; Ryuji Kato; Eiji Kozawa; Shunsuke Hamada; Tomohisa Sakai; Naoki Ishiguro
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 5.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

6.  Assessment of the evolution of cancer treatment therapies.

Authors:  Manuel Arruebo; Nuria Vilaboa; Berta Sáez-Gutierrez; Julio Lambea; Alejandro Tres; Mónica Valladares; Africa González-Fernández
Journal:  Cancers (Basel)       Date:  2011-08-12       Impact factor: 6.639

Review 7.  Modified Nanoparticles as Potential Agents in Bone Diseases: Cancer and Implant-Related Complications.

Authors:  Karol P Steckiewicz; Iwona Inkielewicz-Stepniak
Journal:  Nanomaterials (Basel)       Date:  2020-04-01       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.